Myers Scott Dunseth Insider Trades

Insider Trading History

Track insider trading activity for Myers Scott Dunseth. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Zentalis Pharmaceuticals
Zentalis Pharmaceuticals ZNTL
Director
Holding Value $1.46M 395,895 shares
Last Trade
Jun 16, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$214k 57,100 shares
$3.75
$3.68
Dynavax Technologies
Dynavax Technologies DVAX
Director
Holding Value $0 0 shares
Last Trade
Feb 10, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$2.58M 166,579 shares
$15.50
$15.50
Dynavax Technologies
Dynavax Technologies DVAX
Director
Holding Value $0 0 shares
Last Trade
Feb 10, 2026 Sale (Tender)Reported as Tender on SEC Form 4.
$58.9k 3,800 shares
$15.50
$15.50
Dynavax Technologies
Dynavax Technologies DVAX
Director
Holding Value $543k 35,004 shares
Last Trade
Aug 22, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$41.1k 3,800 shares
$10.82
$15.50
Zentalis Pharmaceuticals
Zentalis Pharmaceuticals ZNTL
Director
Holding Value $1.25M 338,795 shares
Last Trade
Jun 17, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$86.4k 57,603 shares
$1.50
$3.68
Dynavax Technologies
Dynavax Technologies DVAX
Director
Holding Value $484k 31,204 shares
Last Trade
Jun 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$290k 28,500 shares
$10.18
$15.50
Zentalis Pharmaceuticals
Zentalis Pharmaceuticals ZNTL
Director
Holding Value $1.03M 281,192 shares
Last Trade
Apr 30, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$29.4k 21,000 shares
$1.40
$3.68
Zentalis Pharmaceuticals
Zentalis Pharmaceuticals ZNTL
Director
Holding Value $958k 260,192 shares
Last Trade
Nov 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.02M 260,192 shares
$3.92
$3.68
Dynavax Technologies
Dynavax Technologies DVAX
Director
Holding Value $394k 25,446 shares
Last Trade
May 23, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$267k 22,500 shares
$11.85
$15.50
Harpoon Therapeutics
Harpoon Therapeutics HARP
Director
Holding Value $0 0 shares
Last Trade
Mar 11, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$674k 29,298 shares
$23.01
$23.01
Harpoon Therapeutics
Harpoon Therapeutics HARP
Director
Holding Value $522k 22,666 shares
Last Trade
Jan 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$23.3k 2,048 shares
$11.37
$23.01
Harpoon Therapeutics
Harpoon Therapeutics HARP
Director
Holding Value $474k 20,618 shares
Last Trade
Nov 27, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$48.7k 5,000 shares
$9.74
$23.01
Selecta Biosciences
Selecta Biosciences SELB
Director
Holding Value $0 0 shares
Last Trade
Nov 13, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$183k 207,500 shares
$0.88
$0.88
Cartesian Therapeutics
Cartesian Therapeutics RNAC
Director
Holding Value $0 0 shares
Last Trade
Nov 13, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$77.1k 87,500 shares
$0.88
$10.18
Harpoon Therapeutics
Harpoon Therapeutics HARP
Director
Holding Value $359k 15,618 shares
Last Trade
Oct 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$23.4k 5,797 shares
$4.03
$23.01
Harpoon Therapeutics
Harpoon Therapeutics HARP
Director
Holding Value $2.26M 98,215 shares
Last Trade
Jul 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$253k 35,634 shares
$7.10
$23.01
Harpoon Therapeutics
Harpoon Therapeutics HARP
Director
Holding Value $1.06M 46,000 shares
Last Trade
Jun 22, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$306k 46,000 shares
$6.66
$23.01
Dynavax Technologies
Dynavax Technologies DVAX
Director
Holding Value $349k 22,500 shares
Last Trade
May 26, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$312k 27,857 shares
$11.20
$15.50
Viridian Therapeutics
Viridian Therapeutics VRDN
Chief Executive Officer
Holding Value $4.48M 259,500 shares
Last Trade
Apr 12, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$101k 4,000 shares
$25.37
$17.28
Harpoon Therapeutics
Harpoon Therapeutics HARP
Director
Holding Value $1.44M 62,581 shares
Last Trade
Apr 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$260k 34,925 shares
$7.44
$23.01

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up